Login / Signup

Epidemiological analysis of achalasia in Japan using a large-scale claims database.

Hiroki SatoHiroshi YokomichiKazuya TakahashiKentaro TominagaTakeshi MizusawaNaruhiro KimuraYuzo KawataShuji Terai
Published in: Journal of gastroenterology (2019)
In Japan, the incidence and period prevalence of achalasia is comparable to that in other countries. The absolute risk of esophageal carcinoma is rather low. Esophageal dilation has been the mainstay of achalasia treatment, and the role of POEM has increased annually.
Keyphrases
  • risk factors
  • adverse drug